Tag: AstraZeneca
Median FTSE 100 CEO pay rises to record high
AstraZeneca’s chief executive, Sir Pascal Soriot, tops the list with £16.85m, High Pay Centre research reveals.
Consultants push up executive pay
When pay consultants include existing clients in peer groups for comparison, it results in CEO remuneration rising, research found.
LSE chief claims remco chairs willing to suffer ‘naughty step’ for higher executive pay
Julia Hoggett says Capital Markets Industry Taskforce’s campaign to enhance CEO pay is winning converts.
News round-up: this week in governance
Plus500 fintech faces major pay revolt; FRC fines auditors £14m; investor pressure here to stay; disclosure ‘may fail to help ESG’.
News round-up: this week in governance
Activists disrupt Unilever AGM; how AI might save ESG; a difficult pill for Smith & Nephew; should the FCA name and shame?
News round-up: this week in governance
Shareholders accept remuneration policies; EU corporate sustainability directive voted into law; when directors become activists.
Executive pay debate intensifies with proxy advisors in the firing line
Big pharma chair Michel Demaré points to proxy advisors as cause of block on higher pay while more FTSE 100 companies plan boost to packages.
Should UK CEO pay be increased?
There are unanswered questions about the nature of competition between UK and US businesses that need to be considered first.
Diageo announces NED appointment
GSK’s Julie Brown will join the board of directors as a non-executive director and auditco chair on 5 August.
Deliveroo appoints non-executive director
Technology specialist Shobie Ramakrishnan will join the global online food delivery company as a NED in January.